Table 3.
Blood biochemistry: total, HDL and LDL cholesterol, triglyceride, glucose and insulin and HOMA-index of insulin resistance at baseline and the end of each phase (n = 37).
| Baseline | End of Active Phase | End of Placebo Phase | Difference (Active, Placebo) | ||
|---|---|---|---|---|---|
| Biochemistry | Mean ± SD | Mean ± SEM | Mean ± SEM | Mean ± SEM | p |
| Glucose (mmol/L) | 5.18 ± 0.64 | 5.20 ± 0.11 | 5.15 ± 0.12 | 0.05 ± 0.07 | 0.440 |
| Insulin (mmol/L) | 6.31 ± 2.90 | 7.32 ± 0.52 | 6.80 ± 0.58 | 0.51 ± 0.37 | 0.177 |
| HOMA-IR | 1.40 ± 0.69 | 1.72 ± 0.14 | 1.58 ± 0.15 | 0.14 ± 0.10 | 0.173 |
| Triglycerides (mmol/L) | 1.50 ± 1.11 | 1.34 ± 0.09 | 1.40 ± 0.12 | −0.06 ± 0.08 | 0.449 |
| HDL cholesterol (mmol/L) | 1.36 ± 0.26 | 1.29 ± 0.04 | 1.30 ± 0.04 | −0.07 ± 0.02 | 0.499 |
| LDL cholesterol (mmol/L) | 3.82 ± 0.93 | 3.78 ± 0.15 | 3.85 ± 0.16 | −0.17 ± 0.10 | 0.504 |
| Total cholesterol (mmol/L) | 5.80 ± 0.98 | 5.70 ± 0.15 | 5.83 ± 0.16 | −0.13 ± 0.09 | 0.163 |
| Total/HDL ratio | 4.39 ± 1.11 | 4.46 ± 0.20 | 4.63 ± 0.20 | −0.07 ± 0.09 | 0.438 |